Hidradenitis Suppurativa (HS) Completed Phase 2 Trials for Infliximab (DB00065)

Also known as: Hidradenitis Suppurativa / Hidradenitis / Sweat gland inflammation / Acne inversa

IndicationStatusPhase
DBCOND0054533 (Hidradenitis Suppurativa (HS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00795574Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis SuppurtativaTreatment